Investor call link
Awaiting price reaction for this filing.
Krishna Institute of Medical Sciences Limited (KIMS) has informed the stock exchanges that the audio recording of its conference call with investors and analysts held on May 13, 2025 to discuss Q4 FY25 results is now available on the company's website. The recording can be accessed under the Investors section, under disclosures related to SEBI LODR Regulation 46. This is a routine regulatory filing under Regulation 30 and 46(2) of SEBI's Listing Obligations and Disclosure Requirements. No specific financial numbers, guidance, or strategic commentary are contained in this filing itself; it only directs investors to the audio recording.
This is a routine compliance disclosure and is unlikely to have any direct impact on the stock price. Investors seeking management commentary on Q4 FY25 performance, margins, or outlook should listen to the linked audio recording for actual insights.